Rifaximin drug manufacturer is a semisynthetic derivative of rifampicin, another antibiotic. It works by inhibiting bacterial RNA synthesis, effectively preventing the growth and reproduction of harmful bacteria in the intestines. Unlike many antibiotics, Rifaximin is poorly absorbed into the bloodstream, which allows it to act locally within the gastrointestinal tract. This property makes it particularly useful for treating gastrointestinal infections without causing significant disruption to the body’s overall microbial balance.
top of page
bottom of page